Centene, Humana Post Solid Second-Quarter Results

Centene Corp. and Humana Inc. both reported slightly better-than-expected second quarter 2021 results, which Wall Street met with cautious optimism. While executives from both health insurers preached caution due to the Delta variant-driven resurgence of the COVID-19 pandemic, analysts projected both firms to be profitable for the rest of the year.

Centene generated $1.25 in adjusted earnings per share, which beat Wall Street’s consensus EPS projection of $1.21. Meanwhile, Humana reported adjusted EPS of $6.89, exceeding Wall Street’s projected EPS of $6.83.

Delta Overshadows Centene Results

Centene CEO Michael Neidorff sounded a note of caution during a July 27 conference call discussing the results.

“With the continued rise in the highly virulent Delta strain of COVID-19, I must open our call with similar comments to those made this time last year,” Neidorff said, according to a transcript from the Motley Fool. “The variant is real, and we are taking it very seriously. You have seen us execute strongly throughout the pandemic, and that will not change, especially as it remains clear that the pandemic is not over and the environment could remain choppy for the balance of the year.”

0 Comments
© 2021 MMIT

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured-Image-radar-on-drug-benefits-COVID-19-Treatment-Candidates-at-a-Glance.jpg
December 3

Health Insurers Embrace Vaccine Requirements for Workers

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/12/WordPress-Featured_AdobeStock_23041642.jpg
December 3

TeamHealth Wins One Battle in Ongoing War With UnitedHealth

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/09/MCO-Stock-Performance-August-2021.jpg
December 3

Optum Dominates UnitedHealth’s Investor Day, Growth Strategy

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today